Medicine & Health

WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.

WashU researchers have received a federal grant to study the mechanobiological properties of tendons, work that could help to prevent common tendon injuries as well as inform new treatment strategies.

Tammie L.S. Benzinger, MD, PhD, and Thomas H. Schindler, MD, PhD, both of WashU Medicine’s Mallinckrodt Institute of Radiology, have been recognized with prestigious awards from the Society for Nuclear Medicine & Molecular Imaging.

Using machine learning, researchers at WashU Bursky Public Health identified the factors most strongly linked to poor sleep during late pregnancy.

Biomedical engineers at WashU have created a new platform to study mechanobiology, which can help with research on cancer and fibrosis.

Yin Cao, ScD, an associate professor in the Division of Public Health Sciences in the WashU Medicine Mary Culver Department of Surgery, has been named a 2026 Fellow of the 101st class of the John Simon Guggenheim Memorial Foundation.

An AI-enabled software tool developed by WashU Medicine researchers is the first device to predict malignant cerebral edema, a dangerous complication of acute stroke.

WashU Medicine researchers have shown in mice that a medication-design technique in which modular components of anti-cancer drugs are administered separately and assembled in the body — using what’s known as “click chemistry” — is more effective than standard treatments at targeting and shrinking tumors.

Studying mice, WashU Medicine researchers have identified communication signals linking skeletal muscle, the brain and brown fat tissue that play an important role in aging. Interventions in older mice that restore the signaling to that of young mice could promote healthier aging.

C-BRAIN, the consortium co-founded by WashU Medicine and directed by neurologist Randall J. Bateman, MD, brings together members from academia, major pharmaceutical companies and philanthropic organizations.